Remdesivir is a fairly potent inhibitor of coronavirus replication with no obvious toxicity. It may or may not work as a pill but this is irrelevant at this time since it will probably be given IV. In another study in rhesus monkeys, data indicated that a significant concentration of the drug will be found in the blood and that an adequate quantity of the drug should be delivered to the sites where it is needed.

Given the properties of remdesivir as well as the desperate need for a coronavirus therapy, I would estimate that the drug has at least a 50% chance of becoming the first drug to treat the virus. (5)

Let’s hope I’m right.